CN Patent

CN117794535A — 用于治疗肥厚型心肌病的方法

Assigned to Cytokinetics Inc · Expires 2024-03-29 · 2y expired

What this patent protects

本文阐述了用于治疗梗阻性肥厚型心肌病的方法。所述治疗方法包括施用心脏肌凝蛋白抑制剂(CK‑3773274，也称为CK‑274或阿非康坦)并且可包括基于超声心动图的一个或多个组分来滴定所施用日剂量。所述日剂量可基于所述超声心动图增加、维持、减少或终止。

USPTO Abstract

本文阐述了用于治疗梗阻性肥厚型心肌病的方法。所述治疗方法包括施用心脏肌凝蛋白抑制剂(CK‑3773274，也称为CK‑274或阿非康坦)并且可包括基于超声心动图的一个或多个组分来滴定所施用日剂量。所述日剂量可基于所述超声心动图增加、维持、减少或终止。

Drugs covered by this patent

Patent Metadata

Patent number: CN117794535A
Jurisdiction: CN
Classification: —
Expires: 2024-03-29
Drug substance claim: No
Drug product claim: No
Assignee: Cytokinetics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.